Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Senate Bill 433 in Louisiana proposes legislative changes to expand Medicaid coverage for GLP-1 receptor agonist medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) for the treatment of obesity in qualified Medicaid beneficiaries
cannot be purchased
Phenotypic subtypes of OSA: a challenge and opportunity for precision medicine
These drugs were first approved to help regulate blood sugar in people with type 2 diabetes but were later discovered to promote weight loss, among other health benefits
Ozempic, which is used for diabetes, costs roughly $15,000 to $16,000 per year, while Rybelsus, the oral version, also exceeds $14,000 annually (Medi-Span Price Rx, n.d.)
This is because muscle helps control blood sugar after meals and plays an important role in keeping bones strong, according to study lead researcher Melanie Haines, M.D., of Massachusetts General Hospital and Harvard Medical School in Boston, Mass
US$ 21.38
US$ 23.05
US$ 24.56
US$ 28.28
